Molecular Endocrinology has retracted a 2010 study by researchers at the Medical College of Georgia. According to the Spartan retraction notice (we added a link): Continue reading Georgia (well, the Medical College there, anyway) on our minds for a mysterious retraction
This morning we reported on a new retraction in Cell involving fraud from a lab in Finland, which led us to a second retraction of a paper by the same group in the Journal of Molecular Biology. The first author on both papers was Tatjana Degenhardt, who at the time was a graduate student in the lab of Carsten Carlberg, professor of biochemistry at the University of Kuopio.
A few minutes ago Retraction Watch spoke with Carlberg, who had this to say about Degenhardt: Continue reading More on the latest Cell retraction: PI says a graduate student was at fault
Yesterday, we noted that Axel Ullrich, a decorated cancer researcher, had retracted two papers in the Journal of Biological Chemistry. The journal gave no explanation for the retractions, and our conversation with the publication director for the American Society for Biochemistry and Molecular Biology, which puts out the journal, was less than illuminating. This morning, Ullrich responded to all of the questions we sent him by email, and our follow-ups. The picture is now a lot more clear.
Ullrich tells Retraction Watch that he found out from a “private investigator” several months ago that the papers’ lead author, Naohito Aoki, had manipulated their figures. Aoki was a postdoc in Ullrich’s lab in the early 1990s: Continue reading Update on Axel Ullrich retractions: Lead author manipulated figures, says Ullrich
A day after an up and coming Harvard stem cell scientist retracted a Nature paper, Blood has issued a notice of concern about another paper by the same group, published in August 2008, the Boston Globe reports. Such notices often, but not always, precede retractions.
According to the notice for “Osteolineage niche cells initiate hematopoietic stem cell mobilization”: Continue reading Blood posts “notice of concern” over second Wagers-Mayack paper
A Cell paper reporting on genetic mutations responsible for a form of muscular dystrophy was retracted earlier this month. According to the retraction:
Our paper reported the identification of mutations in the gene VMA21 in patients with X-linked myopathy with excessive autophagy (XMEA) and characterized the molecular mechanisms underlying the disease phenotype. Many of the figure panels in the paper summarize data from multiple experiments. We have now detected a number of errors in these panels. Although we stand by the validity of our conclusions, we believe that the most responsible course of action is to retract our paper. We are preparing an expanded version of our work for future submission. We deeply regret this circumstance and apologize to the community.
One of the original authors, Dr. Aubourg, could not be reached regarding this Retraction.
The study has been cited 11 times, according to Thomson Scientific’s Web of Knowledge. Here’s a press release the researchers’ hospital, Sick Kid’s of Toronto, sent out when it was originally published.
Last month, we wrote about the retraction of a 2005 paper suggesting that some adult stem cells might give rise to cancer. That, of course, would be a problem if researchers tried treating heart disease and other conditions with them. The paper’s authors retracted it, however, when it became clear that instead of being transformed — that’s the scientific word for “became cancerous” — the cells had simply become contaminated and overgrown with tumor cells used in research.
We had some questions for the authors of the original paper, and for the editor of the journal. Last week, we heard back from one of the paper’s authors, Javier Garcia-Castro, who had been on vacation without Internet access for weeks. In an email to Retraction Watch, Garcia-Castro wrote: Continue reading Update on stem cell-cancer link retraction: Why not everyone signed, and why authors ended up in another journal first
The study was published four months ago, but managed in its brief lifespan to garner significant attention in the mainstream media and the blogosphere, although it has not been cited by any other papers. It comes alongside growing interest in the potential lnks between shift work and various health conditions including irritable bowel syndrome and breast cancer. Denmark even awards damages to shift workers who have developed the latter.
Ironically, the researchers, led by Philip Tucker, of Swansea University in Wales, U.K., had hoped to demonstrate the toll of shift work that previous studies were unable to show conclusively because of “methodological difficulties”: Continue reading Shifting gears: Occupational health journal pulls study linking shift work, age and sleep disorders
Marc Hauser, a prominent Harvard psychology researcher and author, will be taking a leave of absence from the university following “a lengthy internal investigation found evidence of scientific misconduct in his laboratory” that has led to the retraction of one of his papers, according to The Boston Globe.
The retraction, of a 2002 paper in Cognition, reads, in part: “An internal examination at Harvard University . . . found that the data do not support the reported findings. We therefore are retracting this article,” the Globe reports. It also includes the sentence “MH accepts responsibility for the error.”
The retraction notice does not yet appear anywhere on the journal’s site, where the PDF version of the study is still available, nor on the Medline abstract. Its circumstances appear to be atypical, according to the Globe: Continue reading Monkey business? 2002 Cognition paper retracted as prominent psychologist Marc Hauser takes leave from Harvard